mybacs
Zug
About mybacs
mybacs is a research-driven DTC company specialized in the human microbiome. Our goal is to revolutionize the market around intestinal healthcare and thus make a decisive contribution to the daily well-being of our customers. Our team of pharmaceutical scientists and physicians is focused on the development of innovative and highly-dosed synbiotic supplements. These are aligned by our singular formulations from specifically selected probiotic cultures, prebiotics as well as minerals and vitamins tailored to the individual needs of our customers.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $7.7M
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2023)
- Website: mybacs.com
- Phone: [email protected]
Industries & Categories
Consumer Goods, E-Commerce, Health Care, Personal Health
Social Profiles
Canonical: https://fsome.com/organization/mybacs-84779 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.